Aimei Health Technology Files 8-K on Financial Obligations
Ticker: AFJKR · Form: 8-K · Filed: Dec 13, 2024 · CIK: 1979005
Sentiment: neutral
Topics: financial-obligation, sec-filing, corporate-action
TL;DR
Aimei Health Tech (AMHT) filed an 8-K on 12/13 for new financial obligations. Details on shares, rights, and units.
AI Summary
Aimei Health Technology Co., Ltd. filed an 8-K on December 13, 2024, reporting the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. The filing, dated December 11, 2024, pertains to the company's ordinary shares, rights, and units.
Why It Matters
This filing indicates a change in Aimei Health Technology's financial structure or commitments, which could impact its financial health and investor outlook.
Risk Assessment
Risk Level: medium — The filing concerns financial obligations, which inherently carry risk, but the specific nature and impact are not detailed in this summary.
Key Players & Entities
- Aimei Health Technology Co., Ltd. (company) — Registrant
- December 11, 2024 (date) — Date of earliest event reported
- December 13, 2024 (date) — Filing Date
FAQ
What specific financial obligation is Aimei Health Technology Co., Ltd. reporting?
The filing states the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specific details of this obligation are not provided in the summary.
What is the exact date of the event triggering this 8-K filing?
The date of the earliest event reported is December 11, 2024.
When was this 8-K filing submitted to the SEC?
The filing was submitted on December 13, 2024.
What types of securities are mentioned in relation to this filing?
The filing mentions ordinary shares, rights exchangeable into ordinary shares, and units consisting of ordinary shares and rights.
Where is Aimei Health Technology Co., Ltd. incorporated?
Aimei Health Technology Co., Ltd. is incorporated in the Cayman Islands.
Filing Stats: 795 words · 3 min read · ~3 pages · Grade level 13.7 · Accepted 2024-12-13 16:05:20
Key Financial Figures
- $0.0001 — registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Mar
- $227,000 — the Termination Date An aggregate of $227,000 (the " Extension Payment ") has been de
- $0.033 — r its public shareholders, representing $0.033 per public share, which enables the Com
- $113,500 — ween the Payees, with each contributing $113,500, to fund the Extension Payment . The Pr
- $10.00 — ate units of the Company, at a price of $10.00 per unit, each consisting of one ordina
Filing Documents
- form8-k.htm (8-K) — 50KB
- ex10-1.htm (EX-10.1) — 5KB
- ex10-1_001.jpg (GRAPHIC) — 595KB
- ex10-1_002.jpg (GRAPHIC) — 548KB
- ex10-1_003.jpg (GRAPHIC) — 663KB
- ex10-1_004.jpg (GRAPHIC) — 38KB
- ex10-1_005.jpg (GRAPHIC) — 99KB
- 0001493152-24-049990.txt ( ) — 2958KB
- afjk-20241211.xsd (EX-101.SCH) — 4KB
- afjk-20241211_def.xml (EX-101.DEF) — 30KB
- afjk-20241211_lab.xml (EX-101.LAB) — 37KB
- afjk-20241211_pre.xml (EX-101.PRE) — 27KB
- form8-k_htm.xml (XML) — 7KB
01 Exhibits
Item 9.01 Exhibits. (d) Exhibits Exhibit No. Description 10.1 Promissory Note, dated December 11, 2024, by and among Aimei Health Technology Co., Ltd, Aimei Health Ltd, and United Hydrogen Group Inc . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 13, 2024 Aimei Health Technology Co., Ltd By: /s/ Junheng Xie Name: Junheng Xie Title: Chief Executive Officer and Director (Principal Executive Officer)